Group 1 - China Shipbuilding Defense expects a net profit of 940 million to 1.12 billion yuan for 2025, an increase of 149.61% to 196.88% year-on-year [1] - China First Heavy Industries has only undertaken a small number of related accessory projects and has not generated revenue from them [2] - Huanyu Electronics plans to invest 30 million yuan in a private equity fund focused on AI and emerging industries [3] Group 2 - Zhixiang Jintai's GR1803 injection has been included in the priority review list by the National Medical Products Administration [4] - JianKai Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [5] - Debon Holdings will continue to suspend trading from January 12 due to significant matters being planned [6] Group 3 - South Network Technology's shareholder intends to transfer 847.05 million shares, accounting for 1.50% of the total share capital [7] - Hengrui Medicine has received approval for clinical trials of four drugs [8] - Daotong Technology expects a net profit of 900 million to 930 million yuan for 2025, a year-on-year increase of 40.42% to 45.10% [10] Group 4 - Betta Pharmaceuticals has invested 50 million yuan to acquire a 20% stake in Hangzhou Zhixing Pharmaceutical [11] - Tianyu Biology reported a 10.38% year-on-year decline in cumulative sales revenue for 2025 [12] - Lifang Pharmaceutical's subsidiary has obtained a drug registration certificate for a pain relief product [13] Group 5 - R&F Properties reported a total sales revenue of approximately 14.21 billion yuan for 2025 [14] - Wanfu Biology expects a net profit decline of 87.71% to 91.81% for 2025 [15] - Dazhi expects a negative net profit for 2025 [16] Group 6 - Dongzhu Ecology is negotiating to terminate the acquisition of control over a satellite communication company [17] - Baotai has received a milestone payment of 10 million USD from Hikma Pharmaceuticals [18] - Huace Navigation expects a net profit of 670 million to 690 million yuan for 2025, a year-on-year increase of 14.84% to 18.27% [19] Group 7 - Shenzhen Gas reported a net profit decline of 3.45% for 2025 [20] - Baogang Co. plans to adjust the price of rare earth concentrate for Q1 2026 to 26,834 yuan per ton [21] - Jiuding Investment expects to report a loss for 2025 [22] Group 8 - Shanghai Pharmaceuticals has received a drug registration certificate for a treatment for myasthenia gravis [23] - Hualan Biological plans to acquire a 35% stake in Guangfeng Capsule [24] - Ruina Intelligent plans to invest 169.9 million yuan in a new R&D production base for heat pumps [25] Group 9 - Wantong Development expects to report a loss for 2025 [26] - Xianghe Industrial has completed the purchase of a 5% stake in Hezhixiang Technology [27] - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Commission [28] Group 10 - Xiaoming Co. reported a 37.07% year-on-year decline in chicken product sales revenue for December 2025 [29] - Luokai Co. won a procurement project from State Grid Fujian Power worth approximately 48.2 million yuan [30] - Minhe Co. reported a 65.22% year-on-year increase in the sales of commodity chick seedlings for December 2025 [31] Group 11 - Zhenghai Biological has obtained a registration certificate for calcium silicate bio-ceramic materials [32] - Three Gorges Energy reported a 5.99% year-on-year increase in cumulative total power generation for 2025 [33] - Huisheng Biological expects a net profit of 235 million to 271 million yuan for 2025 [34] Group 12 - Maihe Co. announced the release of the detention measures against its chairman [35] - Wandong's Alzheimer's project has been included in a national major special project for innovative drug development [36] - Kangxin New Materials plans to transfer forest land assets with a book value of 1.203 billion yuan [37] Group 13 - Greenland Holdings expects a net loss of 16 billion to 19 billion yuan for 2025 [39] - Zhongxin Fluorine Materials has obtained a pesticide production license [40]

Core Viewpoint - Dazhihui (601519.SH) announced that it expects to report a negative net profit attributable to shareholders for the fiscal year 2025, indicating that the company will experience a loss in its annual operating performance [1] Financial Performance - The company’s financial department has conducted preliminary calculations, leading to the expectation of a negative net profit for 2025 [1]

Group 1 - The company Dazhihui announced an earnings forecast indicating that it expects to report a net profit attributable to shareholders of the listed company to be negative for the fiscal year 2025, suggesting an anticipated operating loss for that year [1] Group 2 - The article features an exclusive interview with a Tesla FSD (Full Self-Driving) user who claims to have driven 4,400 kilometers without taking control of the steering wheel, highlighting the effectiveness of Tesla's "pure vision" approach [1] - The individual interviewed is a lidar salesperson, raising questions about their support for Tesla's vision-based technology over traditional lidar systems [1]

Core Viewpoint - The company, Dazhihui (601519), announced on January 9 that it expects to report a negative net profit attributable to shareholders for the fiscal year 2025, indicating an anticipated operating loss for that year [1]. Financial Performance - The company’s financial department has conducted preliminary assessments, leading to the expectation of a loss in the 2025 annual operating performance [1].

Financial Performance Forecast - Shanghai Dazhihui Co., Ltd. expects a net profit attributable to shareholders to be negative for the fiscal year 2025[2] - The preliminary estimate indicates that the company will incur a loss in its operating performance for 2025[3] - The performance forecast has not been audited by registered accountants[3] - The performance forecast period is from January 1, 2025, to December 31, 2025[3] Communication and Disclosure - The company will communicate with the annual audit accountants during the preparation of the annual report[3] - Any significant changes that may affect the accuracy of the performance forecast will be disclosed in a timely manner[3] - Investors are advised to pay attention to investment risks associated with the preliminary performance forecast[5] - The announcement was made by the Board of Directors of Shanghai Dazhihui Co., Ltd. on January 10, 2026[6]

（文章来源：每日经济新闻） 每经AI快讯，1月9日，大智慧发布2025年度业绩预告，预计归属于上市公司股东的净利润为负值，公 司年度经营业绩将出现亏损。 ...

Core Viewpoint - The company anticipates a negative net profit attributable to shareholders for the fiscal year 2025, indicating an expected operational loss [1] Financial Performance - The profit forecast has not been audited by a registered accountant, and specific figures will be disclosed later on the Shanghai Stock Exchange website [1] - The company will maintain communication with the annual audit accountant during the preparation of the annual report, and will fulfill information disclosure obligations if there are significant changes [1]

Core Viewpoint - The company anticipates a negative net profit attributable to shareholders for the fiscal year 2025, indicating an expected operational loss [1] Financial Performance - The profit forecast has not been audited by a registered accountant, and specific figures will be disclosed later on the Shanghai Stock Exchange website [1] - The company will maintain communication with the annual audit accountant during the annual report preparation process, and any significant changes will be disclosed in a timely manner [1]

Group 1 - The virtual robot sector experienced a decline of 2.9% [1] - Among the companies, Winshang fell by 7.66%, Jinzheng shares dropped by 3.88%, and Tonghuashun decreased by 3.77% [1] - Other companies such as Dongfang Caifu, Dingjie Zhizhi, and Dazhihui also saw declines exceeding 2% [1]

Group 1 - The core viewpoint of the news is that Dazhihui's stock has experienced fluctuations, with a recent decline of 2.03% and a total market value of 28.783 billion yuan [1] - As of January 7, Dazhihui's stock price is reported at 14.47 yuan per share, with a trading volume of 1.4 billion yuan and a turnover rate of 4.77% [1] - The company has seen a year-to-date stock price increase of 12.43%, with a 5-day increase of 11.39% and a 20-day increase of 7.90%, while experiencing a 60-day decline of 9.56% [1] Group 2 - As of September 30, Dazhihui has 166,000 shareholders, an increase of 24.23% from the previous period, with an average of 11,980 circulating shares per person, a decrease of 19.50% [2] - For the period from January to September 2025, Dazhihui achieved operating revenue of 564 million yuan, a year-on-year increase of 8.78%, while reporting a net profit attributable to shareholders of -29.5624 million yuan, a year-on-year increase of 85.30% [2] Group 3 - Dazhihui has distributed a total of 174 million yuan in dividends since its A-share listing, with no dividends distributed in the past three years [3] - As of September 30, 2025, the sixth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 20.9309 million shares, a decrease of 6.5186 million shares from the previous period [3] - The seventh largest circulating shareholder is Huabao Zhongzheng Financial Technology Theme ETF, which is a new shareholder holding 16.7736 million shares [3]